Agilent Technologies (FRA:AG8) Total Equity: €6,089 Mil (As of Apr. 2026)


FRA:AG8 Agilent Technologies Inc FRA:AG8
94 GF Score
Price €112.55
GF Value €127.46
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Agilent Technologies Total Equity?

Agilent Technologies FRA:AG8 -1.92% 94 Total Equity is €6,089 Mil as of Apr. 2026. GuruFocus rates FRA:AG8 with a GF Score™ of 94/100 and a GF Value™ of €127.46 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Agilent Technologies's total equity for the quarter that ended in Apr. 2026 was €6,089 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Agilent Technologies Total Equity Historical Data

* Premium members only.

The historical data trend for Agilent Technologies's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agilent Technologies Total Equity Chart

Agilent Technologies Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,645.32 5,384.58 5,535.22 5,414.36 5,790.52

Agilent Technologies Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,461.04 5,459.09 5,790.52 5,878.71 6,089.31
FRA:AG8
94GF Score
Agilent Technologies Inc FRA:AG8
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agilent Technologies Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Agilent Technologies's Total Equity for the fiscal year that ended in Oct. 2025 is calculated as

Total Equity=Total Assets(Q: Oct. 2025 )-Total Liabilities(Q: Oct. 2025 )
=10932.493-5141.974
=5,791

Agilent Technologies's Total Equity for the quarter that ended in Apr. 2026 is calculated as

Total Equity=Total Assets(Q: Apr. 2026 )-Total Liabilities(Q: Apr. 2026 )
=11170.575-5081.265
=6,089

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €6,089 Mil mean?
Agilent Technologies (FRA:AG8) has a Total Equity of €6,089 Mil as of Apr. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Agilent Technologies and its competitors.
Is Agilent Technologies' Total Equity too high?
Agilent Technologies' current Total Equity is €6,089 Mil. Overall, Agilent Technologies has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' Total Equity compare to NTRA and WAT?
Agilent Technologies' Total Equity of €6,089 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Diagnostics & Research company?
A good Total Equity depends on the Medical Diagnostics & Research industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Agilent Technologies and its competitors. Agilent Technologies's current Total Equity is €6,089 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (FRA:AG8) is currently considered Modestly Undervalued. The stock's GF Value™ is €127.46, compared to a current price of €112.55 — trading 11.7% below its estimated fair value. The current Total Equity is €6,089 Mil. Agilent Technologies' overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Agilent Technologies (FRA:AG8), the current Total Equity is €6,089 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Agilent Technologies (FRA:AG8) Overvalued in 2026?

Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued. The current stock price of €112.55 is trading 11.7% below its estimated GF Value™ of €127.46. GuruFocus considers Agilent Technologies to be Modestly Undervalued.

Key valuation signals for FRA:AG8:

  • Total Equity: €6,089 Mil
  • GF Value™: €127.46 vs. price of €112.55 (11.7% below fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the FRA:AG8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Agilent Technologies Business Description

Address 5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
94GF Score

Get the complete analysis for FRA:AG8

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€112.55
Price
€127.46
GF Value